Focus and Scope

Focus and Scope

Jurnal Sabdariffarma publishes original research articles, reviews, and short communications written in English (preferred) or Bahasa Indonesia, with bilingual abstracts. The journal serves as a platform for scientific dissemination in all areas of pharmaceutical science and practice, including research that integrates pharmaceutical, clinical, and health science perspectives.

The scope of the journal covers, but is not limited to, the following areas:

• Pharmaceutical Technology and Drug Development
  Studies on formulation design, dosage form innovation, drug delivery systems, nanotechnology-based pharmaceuticals, stability testing, and analytical method development for quality control.
• Pharmacognosy and Natural Product Research
  Exploration, extraction, isolation, standardization, and bioactivity evaluation of medicinal plants and natural products, especially those originating from Indonesian biodiversity.
• Pharmacology and Toxicology
  Experimental and theoretical studies on pharmacodynamics, pharmacokinetics, toxicological evaluation, and mechanism of action of synthetic and natural compounds.
• Pharmaceutical Chemistry
  Research on synthesis, chemical modification, characterization, molecular modeling, and quality assurance of active pharmaceutical ingredients and excipients.
• Clinical Pharmacy and Pharmacotherapy
  Clinical case studies, therapeutic drug monitoring, rational drug use, pharmacovigilance, and evidence-based approaches in patient care and disease management.
• Social and Administrative Pharmacy
  Research on pharmacy practice, pharmaceutical policy, ethics, patient safety, pharmacoeconomics, and health systems management in community and hospital settings.
• Industrial and Regulatory Pharmacy
  Studies on manufacturing processes, quality assurance systems, good manufacturing practices (GMP), regulatory compliance, and supply chain management in the pharmaceutical industry.
• Pharmaceutical Marketing and Management
  Research on pharmaceutical business strategies, innovation management, market analysis, and the digital transformation of pharmaceutical services.

Jurnal Sabdariffarma encourages the publication of innovative findings that support the advancement of pharmaceutical sciences, contribute to the sustainable use of Indonesian medicinal resources, and promote safe, effective, and accessible medication for public health improvement.

For manuscript submission, authors are required to follow the author guidelines provided on the journal’s website. Inquiries may be directed to the editorial office at sabdariffarma@unfari.ac.id.

Peer Review Process

The submitted manuscript is first reviewed by an editor. It will be evaluated in the office for suitability with the journal’s focus and scope, whether it exhibits major methodological flaws, and its similarity score using plagiarism-checking software. (Contoh: usage of similarity screening is recommended by peer review best practices).

If the manuscript passes this initial screening, it will be sent to at least two anonymous reviewers (double-blind review). Reviewers’ comments are then sent to the corresponding author for necessary actions and responses.

The suggested decision will be evaluated in an editorial board meeting. Afterwards, the editor will send the final decision to the corresponding author. Utilizing feedback from the peer-review process, the Editor will make a final publication decision. The review process will typically take approximately 3 to 12 weeks.

Decision categories include:

• Reject – Rejected manuscripts will not be published and authors will not have the opportunity to resubmit a revised version of the manuscript to Sabdariffarma.

• Resubmit for Review – The submission needs to be re-worked, and with significant changes may be reconsidered. However, it will require a second round of review.

• Accept with Revisions – Manuscripts receiving an “accept-pending-revisions” decision will be published in Sabdariffarma under the condition that required modifications (minor or major) are made. Revisions will be reviewed by the editor to ensure necessary updates are completed prior to publication.

• Accept – Accepted manuscripts will be published in their current form with no further modifications required.

Open Access Policy

This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.